Date of Presentation

5-2-2024 12:00 AM

College

Rowan-Virtua School of Osteopathic Medicine

Poster Abstract

Background: In the United States, 2.7% of children are diagnosed with Autism Spectrum Disorder (ASD). Environmental factors such as vitamin levels, including D, B9, and B12, may have a significant impact on the risk of development. Children conceived in winter months, with low sunlight and Vitamin D levels, have a higher risk of developing ASD. Vitamin B12 deficiency is generally linked with an increased risk of neurodevelopmental disorders. Additionally, vitamin B9 deficiency of a mother during gestation is linked to a higher risk of her child developing ASD.

Purpose: To assess potential differences in vitamin levels between patients of differing severities of ASD.

Methods: An analysis of vitamin level data for 295 RISN patients with ASD was conducted. Patients on vitamin supplementation at the time labs were drawn were filtered out. For each vitamin, patients were categorized based on ASD severity level. Using R-Studio, a one-way ANOVA Kruskal-Wallis test between the groups was conducted to determine statistically significant differences.

Results: On analysis, there were no statistically significant differences (p-value = 0.4309) in Vitamin D levels for patients with different severities of ASD. There were no statistically significant differences (p-value = 0.8801) in Vitamin B9 levels between these patients. Additionally, there were no statistically significant differences (p-value = 0.9744) in Vitamin D levels for patients with these different severities of ASD. This indicates, across these three vitamin types, that vitamin concentrations tend to be consistent across patients with ASD.

Conclusions: It may be important to consider repeat studies of this premise, as the sample size, among other factors, may have an influence on the outcome. The lack of notable difference in vitamin level between severities may indicate that severity is unrelated to vitamin level, or that severity is influenced by vitamins in a concentration-independent way, such as processing and receptor sensitivity. Future research should focus on obtaining thorough vitamin labs for patients longitudinally. This will allow for paired analysis of different vitamin levels. It also encourages research into vitamin level changes in patients over time and how it may be related to behavioral changes.

Keywords

Autism Spectrum Disorder, ASD, Vitamin D, Vitamin B12, Vitamin B9, Folate, Neurodevelopmental Disorders

Disciplines

Alternative and Complementary Medicine | Congenital, Hereditary, and Neonatal Diseases and Abnormalities | Medicine and Health Sciences | Nutritional and Metabolic Diseases | Other Chemicals and Drugs | Pathological Conditions, Signs and Symptoms

Document Type

Poster

Share

COinS
 
May 2nd, 12:00 AM

Vitamin Level Differences Across the ASD Spectrum

Background: In the United States, 2.7% of children are diagnosed with Autism Spectrum Disorder (ASD). Environmental factors such as vitamin levels, including D, B9, and B12, may have a significant impact on the risk of development. Children conceived in winter months, with low sunlight and Vitamin D levels, have a higher risk of developing ASD. Vitamin B12 deficiency is generally linked with an increased risk of neurodevelopmental disorders. Additionally, vitamin B9 deficiency of a mother during gestation is linked to a higher risk of her child developing ASD.

Purpose: To assess potential differences in vitamin levels between patients of differing severities of ASD.

Methods: An analysis of vitamin level data for 295 RISN patients with ASD was conducted. Patients on vitamin supplementation at the time labs were drawn were filtered out. For each vitamin, patients were categorized based on ASD severity level. Using R-Studio, a one-way ANOVA Kruskal-Wallis test between the groups was conducted to determine statistically significant differences.

Results: On analysis, there were no statistically significant differences (p-value = 0.4309) in Vitamin D levels for patients with different severities of ASD. There were no statistically significant differences (p-value = 0.8801) in Vitamin B9 levels between these patients. Additionally, there were no statistically significant differences (p-value = 0.9744) in Vitamin D levels for patients with these different severities of ASD. This indicates, across these three vitamin types, that vitamin concentrations tend to be consistent across patients with ASD.

Conclusions: It may be important to consider repeat studies of this premise, as the sample size, among other factors, may have an influence on the outcome. The lack of notable difference in vitamin level between severities may indicate that severity is unrelated to vitamin level, or that severity is influenced by vitamins in a concentration-independent way, such as processing and receptor sensitivity. Future research should focus on obtaining thorough vitamin labs for patients longitudinally. This will allow for paired analysis of different vitamin levels. It also encourages research into vitamin level changes in patients over time and how it may be related to behavioral changes.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.